• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Heart Failure: A Companion to Braunwald's Heart Disease

Heart Failure: A Companion to Braunwald's Heart Disease

9781455772377
690,43 zł
586,87 zł Zniżka 103,56 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 586,87 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD lub Pocztę Polską. Kliknij po więcej szczegółów

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni. Kliknij po więcej szczegółów

Opis

Lead editor of Braunwalds Heart Disease, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring you the latest, definitive state-of-the art information on heart failure in this outstanding Braunwalds companion volume. Heart Failure, 3rd Edition, keeps you current with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients lives and in your practice. Braunwalds Heart Failure Companion also has an on-line version that is updated with late-breaking clinical trials, Hot Off the Press commentary and Focused Reviews that are relevant to heart failure. Heart Failure will be of enormous interest and value to clinicians, investigators, and trainees who are concerned with enriching their understanding of and caring for the ever growing number of patients with this condition. We are proud of this important companion to Heart Disease:: A Textbook of Cardiovascular Medicine. Foreword by:: Eugene Braunwald, Douglas P. Zipes, Peter Libby and Robert O. Bonow, Feb 2015

Szczegóły produktu
Saunders
55797
9781455772377
9781455772377

Opis

Rok wydania
2015
Numer wydania
3
Oprawa
twarda
Liczba stron
784
Wymiary (mm)
222 x 281
Waga (g)
2130
  • Section 1. Basic Mechanisms of Heart Failure

    1. Molecular Basis for Heart Failure

    2. Cellular Basis for Heart Failure

    3. Cellular Basis for Myocardial Regeneration and Repair

    4. Myocardial Basis for Heart Failure: Role of Cardiac Interstitium

    Section 2. Mechanisms of Disease Progression in Heart Failure

    5. Molecular Signaling Mechanisms of the Renin-Angiotensin System in Heart Failure

    6. Adrenergic Receptor Signaling in Heart Failure

    7. Role of Innate Immunity in Heart Failure

    8. Oxidative Stress in Heart Failure

    9. Alterations in Ventricular Function in Systolic Heart Failure

    10. Alterations in Ventricular Function: Diastolic Heart Failure

    11. Alterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart Failure

    12. Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure

    13. Alterations in the Peripheral Circulation in Heart Failure

    14. Alterations in Kidney Function Associated with Heart Failure

    15. Alterations in Skeletal Muscle in Heart Failure

    16. Alterations in Cardiac Metabolism

    Section 3. Etiological Basis for Heart Failure

    17. Epidemiology of Heart Failure

    18. Heart Failure as a Consequence of Ischemic Heart Disease

    19. Heart Failure as a Consequence of Dilated Cardiomyopathy

    20. The Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

    21. Heart Failure As A Consequence of Hypertrophic Cardiomyopathy

    22. Heart Failure as a Consequence of Genetic Cardiomyopathy

    23. Heart Failure as a Consequence of Hypertension

    24. Heart Failure As A Consequence of Valvular Heart Disease

    25. Heart Failure as a Consequence of Congenital Heart Disease

    26. Heart Failure as a Consequence of Viral and Non-viral Myocarditis

    27. Heart Failure in the Developing World

    Section 4. Clinical Assessment of Heart Failure

    28. Clinical Evaluation of Heart Failure

    29. Cardiac Imaging In Heart Failure

    30. The Use of Biomarkers in the Evaluation of Patients with Heart Failure

    31. Hemodynamics in Heart Failure

    Section 5. Therapy for Heart Failure

    32. Disease Prevention in Heart Failure

    33. Management of Acute Decompensated Heart Failure

    34. Contemporary Medical Therapy for Heart Failure Patients With Reduced Ejection Fraction

    35. Management of Arrhythmias and Device Therapy in Heart Failure

    36. Treatment of Heart Failure with Preserved Ejection Fraction

    37. Management of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority Groups

    38. Stem Cell-Based and Gene Therapies in Heart Failure

    39. Pulmonary Hypertension

    40. Cardiac Transplantation

    41. Surgical Treatment of Chronic Congestive Heart Failure

    42. Circulatory Assist Devices in Heart Failure

    43. Managing Heart Failure in Cancer Patients

    44. Disease Management in Heart Failure

    45. Management of Comorbidities in Heart Failure for the third edition of Heart Failure 

    46. Measuring Quality Outcomes in Heart Failure

    47. Decision Making and Palliative Care in Advanced Heart Failure

Komentarze (0)